Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence.

Natia MurvelashviliLuyu XieJeffrey N SchellingerM Sunil MathewElisa Morales MarroquinIldiko Lingvay Sarah E Messiah Jaime P Almandoz

Published in: Obesity (Silver Spring, Md.) (2023)

These results show that treatment regimens including semaglutide 1.0 mg weekly lead to superior weight loss compared with liraglutide 3.0 mg daily for treating post-MBS weight recurrence, regardless of procedure type or the magnitude of weight recurrence.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
physical activity
gastric bypass
obese patients
free survival
weight gain
body mass index
systematic review
randomized controlled trial
minimally invasive
metabolic syndrome
adipose tissue